Develops and manufactures agricultural and noncrop products

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

ImmuneRegen BioSciences, Inc. researches and develops immunomodulation to improve pulmonary function and stimulating the human immune system. The company is headquartered in Scottsdale, AZ.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Xact Laboratories provides personalized medical therapy for health care systems, pharmacies, HIE, and PBMs.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient��s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA.

Clinomics, Inc. conducts bio and medical research activities. It products and services include Clinomics TrioDx RT-PCR, COVID-19 Test (FDA EUA), liquid biopsy, precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.

Diversa Corporation is an industrial biotechnology company that develops high performance enzymes. It extracts microbial DNA directly from collected samples to avoid the often impossible task of growing microbes in the laboratory. It mines its collection of microbial genes, numbering in the billions, using high-throughput screening technologies designed to identify unique enzymes as product candidates. Diversa Corporation develops enzymes that are environmentally friendly and more cost-effective for industries such as the global food and fuel markets. It has developed enzymes  to meet the specific needs of companies in various markets, including grain processing, bio fuels, animal health and nutrition and other industries.

GENOME express SA develops and markets value-added solutions for functional genomics. The company provides a platform that integrates proprietary tools for genomics, transcriptomics and proteomics. GENOME express offers services for international biotechnology, agric-food, veterinary and pharmaceutical companies and for academic laboratories to accelerate their global discovery process. The company was founded in 1994 and is headquartered in Meylan, France.

Haiyang Yellow Sea Products Co., Ltd., established on 2004-07-09, Business scope includes seafood nursery(turbot,Semi-smooth tongue sole,Xu's flat scorpionfish,flounder,Portunus,Chinese prawns,Flounder,black sea bream);Natural salt production and sales and import and export business(The validity period is subject to the license);aquaculture(Waters owned by the whole people are not included,tidal flat farming),retail,Aquatic products,Wholesale and retail of vegetables,refrigeration(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

BioChain provides bio-sample products and analysis services used in advancing translational medicine, companion diagnostics, and clinical product research and development. BioChain’s products are available for DNA and RNA sequencing, PCR and RT-PCR, gene expression analysis, DNA and RNA purification, protein extraction and purification, protein expression analysis, and liquid biopsy studies. BioChain’s One-Stop Services for Next Generation Sequencing (NGS), from clinical sample collection, sample preparation, sequencing to bioinformatics analysis, will revolutionize the industry.

Biocept, an emerging biotechnology leader in cell separation technology, is developing a new, powerful class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The CEEâ„¢ Cell Enrichment and Extraction platform combines sophisticated attachment chemistry with mathematically modeled fluid dynamics to enable earlier, accurate, less invasive diagnoses. Isolation, purification and analysis of rare cells are managed within their state-of-the-art CLIA-accredited laboratory. The clinical laboratory is accredited by the College of American Pathologists (CAP) and holds licenses in California and several other states.

Authentechnologies LLC provides DNA-based species identification services. The firm also provides testing, auditing, certification, and consulting services for companies in the dietary supplement, natural product, food, and seafood industries. Its services include testing laboratory specializing in species identification and genetic fingerprinting for the natural products industries. The company was founded by Danica T. Harbaugh Reynaud in 2010 and is headquartered in Richmond, CA.